Axi-STS: A Clinicopathological phase II study of axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas.

Project Details

Short titleAxi-STS: A Clinicopathological phase II study of axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas.
StatusActive
Effective start/end date1/06/1031/07/24

Funding

  • PFIZER LIMITED
  • Cancer Research Uk